Sentiment: Strong Buy
Streetinsider: Piper Jaffray initiates coverage on Insmed (NASDAQ: INSM) with an Overweight. PT $34.00.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $15.44 yesterday, with a 52 week range of $5.56-$16.31.